Sagoschen, Ingo
Scibior, Barbara
Farmakis, Ioannis T.
Keller, Karsten
Graafen, Dirk
Griemert, Eva-Verena
Vosseler, Markus
Treede, Hendrik
Münzel, Thomas
Knorr, Maike
Gori, Tommaso
Konstantinides, Stavros
Hobohm, Lukas http://orcid.org/0000-0002-4312-0366
Funding for this research was provided by:
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Received: 20 August 2023
Accepted: 7 December 2023
First Online: 19 December 2023
Declarations
:
: I. Sagoschen reports no conflicts of interest. B. Scibior reports no conflicts of interest. K. Keller reports no conflicts of interest. I.T. Farmakis reports no conflicts of interest. D. Graafen reports lecture/consultant fees from Siemens Healthineers. E.V. Griemert reports institutional grants and lecture fees from Edwards Lifesciences Services GmbH, Medtronic GmbH and TRACOE medical GmbH; all outside the submitted work. M. Vosseler reports no conflicts of interests. H. Treede reports no conflicts of interest. T. Münzel reports no conflict of interest. Maike Knorr reports no conflict of interest. T. G. has received grant support (CARIMA study) and speaker´s honoraria from Novartis, speaker´s honoraria from Boehringer Ingelheim, Daiichi-Sankyo, MSD, Pfizer – Bristol-Myers Squibb and Astra Zeneca, outside the submitted work. S.V. Konstantinides reports institutional grants and personal lecture/consultant fees from Bayer AG, Daiichi-Sankyo, and Boston Scientific; and personal lecture/consultant fees from Pfizer–Bristol-Myers Squibb and MSD, all outside the submitted work. L. Hobohm reports lecture/ consultant fees from MSD, Boston Scientific, INARI and Johnson&Johnson, outside the submitted work.